StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) stock

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.13−0.05 (-4.24%)

Close on Nov 17, 2026Market cap $5.45MP/E –Yield –

Alzamend Neuro enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alzamend Neuro's enterprise value was -$1.27M on Nov 11, 2026, against $1.26M a year earlier. Over the last 5 years it ranged from -$2.20M to $587.38M, with a median of $4.86M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.27M-151.4%
2025Dec 31, 2025$2.47M–
2024Dec 31, 2024-$194.79K-103.5%
2023Dec 29, 2023$5.56M-87.6%
2022Dec 30, 2022$44.76M-73.7%
2021Nov 30, 2021$170.31M–

More Alzamend Neuro figures

See a number that looks wrong?